Angeline Brechlin
Clinical Nurse Specialist · Rockford, ILNPI 1689774531
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 9 manufacturers, the largest accounting for just 23.2% — the pattern of someone who eats at a lot of different presentations.
Across 24 payments — averaging $19.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$106
- Lundbeck LLC$84
- Supernus Pharmaceuticals, Inc.$71
- AbbVie$66
- Takeda Pharmaceuticals U.S.A., Inc.$48
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$35
- plus $48 from 3 others
What the payments were for
- Food & beverage$458100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$458 in reported general payments places this provider in the 55th percentile of 93 clinical nurse specialist providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 18 | $2,702 |
| Vilazodone Hcl | 15 | $2,565 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 62 | $1,972 |
| Olanzapine | 66 | $1,769 |
| Alprazolam | 166 | $1,629 |
| Bupropion XlBupropion Hcl | 65 | $1,274 |
| Duloxetine Hcl | 59 | $1,148 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 25 | $1,078 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 55 | $1,055 |
| Trazodone Hcl | 74 | $930 |
| Escitalopram Oxalate | 85 | $773 |
| Quetiapine Fumarate | 35 | $752 |
| Mirtazapine | 43 | $583 |
| Clonazepam | 129 | $534 |
| Bupropion Hcl SrBupropion Hcl | 18 | $498 |
Paid to pharmacies, not to this prescriber.
Other clinical nurse specialist in Rockford
- Tina Marie BaumanBarrington$19K
- Roxanne SiemeckOak Lawn$10K
- Elizabeth MoonLindenhurst$10K
- Joann ErikssonGlenview$8K
- Nicole GraneyOak Lawn$6K
- Amy KatsikasO'Fallon$3K
- Camille RogellChicago$2K
- Kim ScottPeoria$2K
- Mary Jo MikottisElmhurst$2K
- Cheryl HerrmannPeoria$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.